Related references
Note: Only part of the references are listed.CA-125 Change After Chemotherapy in Prediction of Treatment Outcome Among Advanced Mucinous and Clear Cell Epithelial Ovarian Cancers A Gynecologic Oncology Group Study
Chunqiao Tian et al.
CANCER (2009)
Colorectal Hepatic Metastases: Adjuvant Chemotherapy and Survival
David J. Gallagher et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
John K. Chan et al.
GYNECOLOGIC ONCOLOGY (2008)
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Keren Levanon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO group
I. Ray-Coquard et al.
BRITISH JOURNAL OF CANCER (2007)
PIEPOC: A new prognostic index for advanced epithelial ovarian cancer - Japan Multinational Trial Organization OC01-01
Satoshi Teramukai et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer?: Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
O. Tredan et al.
ANNALS OF ONCOLOGY (2007)
Randomized phase III trial of topotecan following carboplatin and paclitaxel in first-line treatment of advanced ovarian cancer:: A gynecologic cancer intergroup trial of the AGO-OVAR and GINECO
Jacobus Pfisterer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: A prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
A du Bois et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon
RT Marquez et al.
CLINICAL CANCER RESEARCH (2005)
Advanced stage mucinous epithelial ovarian cancer: The Hellenic cooperative oncology group experience
D Pectasides et al.
GYNECOLOGIC ONCOLOGY (2005)
Mucinous epithelial ovarian cancer: A separate entity requiring specific treatment
V Hess et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma
ML Gemignani et al.
GYNECOLOGIC ONCOLOGY (2003)
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
I Vergote et al.
LANCET (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results
MJ Piccart et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
